Shares of PureTech Health plc (LON:PRTC – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 126.64 and traded as low as GBX 125.20. PureTech Health shares last traded at GBX 126.20, with a volume of 360,270 shares trading hands.
PureTech Health Stock Performance
The company has a debt-to-equity ratio of 6.33, a quick ratio of 2.51 and a current ratio of 6.59. The company has a market capitalization of £307.19 million, a P/E ratio of -2.74 and a beta of 0.79. The business’s fifty day simple moving average is GBX 126.64 and its 200-day simple moving average is GBX 126.24.
PureTech Health Company Profile
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.
Read More
- Five stocks we like better than PureTech Health
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
